Bio-Techne Corporation (TECH) Citi Annual Global Healthcare Conference 2025 December 3, 2025 3:15 PM EST
Company Participants
James Hippel – Executive VP of Finance & CFO
Conference Call Participants
Patrick Donnelly – Citigroup Inc., Research Division
Presentation
Patrick Donnelly
Citigroup Inc., Research Division
We’ll look to get going here. Thanks for joining us. I’m Patrick Donnelly, the tools and diagnostics analyst here at Citi. I have Jim Hippel from Techne with us today.
Question-and-Answer Session
Patrick Donnelly
Citigroup Inc., Research Division
So Jim, a bunch of different stuff to cover. Maybe we can just start high level as we work our way through the year here for you guys, coming out of fiscal 1Q for you, you guys kind of reset a little bit in terms of the pacing how this year is going to go. Maybe just talk through the expectations for 2Q and then the ramp in the back half and maybe just some of the things to call out that changed a little bit over the course of the last couple of months.
James Hippel
Executive VP of Finance & CFO
Yes, sure. Happy to. So thanks for having us, by the way. Always good to see you.
Patrick Donnelly
Citigroup Inc., Research Division
Yes, of course.
James Hippel
Executive VP of Finance & CFO
Maybe I’ll start a little bit with the dynamics of Q1 because that even parlays into how we’re thinking about Q2 and the rest of the year. So we ended the Q1 with negative 1% growth. We did have 2 of our cell therapy customers, very large customers, who did not purchase any material from us this quarter and likely will not for the remainder of the year, and I’m sure we’ll have some questions in more detail around that. So you got to take out those 2
Read the full article here